Clinical trials in fibrositis: a critical review and future directions.

S. E. Gabriel, C. Bombardier

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

A critical appraisal of the design of clinical trials which examined the effectiveness of various interventions in fibrositis was conducted. Therapeutic interventions included physical fitness, biofeedback, acupuncture, dothiepin, imipramine, cyclobenzaprine, S-adenosylmethionine and amitriptyline. The design and analysis of the randomized, controlled studies render their results reliable. Major areas for methodologic improvement in future trials were identified. Standardized, validated and reliable diagnostic and outcome criteria need to be established. Factors which could predict response need to be identified to enable the selection of the most appropriate patient population for inclusion in future studies. Finally, the incorporation of measures of patient function will result in more clinically meaningful outcome evaluation.

Original languageEnglish (US)
Pages (from-to)177-179
Number of pages3
JournalThe Journal of rheumatology. Supplement
Volume19
StatePublished - Nov 1989
Externally publishedYes

Fingerprint

Fibromyalgia
Dothiepin
Clinical Trials
S-Adenosylmethionine
Amitriptyline
Physical Fitness
Imipramine
Acupuncture
Population
Direction compound
Therapeutics
cyclobenzaprine

ASJC Scopus subject areas

  • Immunology
  • Rheumatology

Cite this

Clinical trials in fibrositis : a critical review and future directions. / Gabriel, S. E.; Bombardier, C.

In: The Journal of rheumatology. Supplement, Vol. 19, 11.1989, p. 177-179.

Research output: Contribution to journalArticle

@article{e63916c6366840cfb20744ea429baf46,
title = "Clinical trials in fibrositis: a critical review and future directions.",
abstract = "A critical appraisal of the design of clinical trials which examined the effectiveness of various interventions in fibrositis was conducted. Therapeutic interventions included physical fitness, biofeedback, acupuncture, dothiepin, imipramine, cyclobenzaprine, S-adenosylmethionine and amitriptyline. The design and analysis of the randomized, controlled studies render their results reliable. Major areas for methodologic improvement in future trials were identified. Standardized, validated and reliable diagnostic and outcome criteria need to be established. Factors which could predict response need to be identified to enable the selection of the most appropriate patient population for inclusion in future studies. Finally, the incorporation of measures of patient function will result in more clinically meaningful outcome evaluation.",
author = "Gabriel, {S. E.} and C. Bombardier",
year = "1989",
month = "11",
language = "English (US)",
volume = "19",
pages = "177--179",
journal = "The Journal of rheumatology. Supplement",
issn = "0380-0903",
publisher = "Journal of Rheumatology",

}

TY - JOUR

T1 - Clinical trials in fibrositis

T2 - a critical review and future directions.

AU - Gabriel, S. E.

AU - Bombardier, C.

PY - 1989/11

Y1 - 1989/11

N2 - A critical appraisal of the design of clinical trials which examined the effectiveness of various interventions in fibrositis was conducted. Therapeutic interventions included physical fitness, biofeedback, acupuncture, dothiepin, imipramine, cyclobenzaprine, S-adenosylmethionine and amitriptyline. The design and analysis of the randomized, controlled studies render their results reliable. Major areas for methodologic improvement in future trials were identified. Standardized, validated and reliable diagnostic and outcome criteria need to be established. Factors which could predict response need to be identified to enable the selection of the most appropriate patient population for inclusion in future studies. Finally, the incorporation of measures of patient function will result in more clinically meaningful outcome evaluation.

AB - A critical appraisal of the design of clinical trials which examined the effectiveness of various interventions in fibrositis was conducted. Therapeutic interventions included physical fitness, biofeedback, acupuncture, dothiepin, imipramine, cyclobenzaprine, S-adenosylmethionine and amitriptyline. The design and analysis of the randomized, controlled studies render their results reliable. Major areas for methodologic improvement in future trials were identified. Standardized, validated and reliable diagnostic and outcome criteria need to be established. Factors which could predict response need to be identified to enable the selection of the most appropriate patient population for inclusion in future studies. Finally, the incorporation of measures of patient function will result in more clinically meaningful outcome evaluation.

UR - http://www.scopus.com/inward/record.url?scp=0024819683&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024819683&partnerID=8YFLogxK

M3 - Article

C2 - 2691677

AN - SCOPUS:0024819683

VL - 19

SP - 177

EP - 179

JO - The Journal of rheumatology. Supplement

JF - The Journal of rheumatology. Supplement

SN - 0380-0903

ER -